Blackstone Life Sciences And Novartis To Launch Cardiovascular Drug Company
The life sciences business of Manhattan-based Blackstone Group is making its first investment, spending $250 million to form a company with drugmaker Novartis, called Anthos Therapeutics, that will... To view the full story, click the title link.
Tiger Global, Softbank Invest In Chinese Life Science Solutions Provider Taimei Technology - China Money Network
Chinese life science technology solutions provider Taimei Technology has secured a US$80 million series E round of financing led by Tiger Global Management, said Taimei Technology at its annual meeting on January 25. Softbank China and Chinese healthcare-focused venture capitalist Cowin Venture also participated in the round.
Alphabet's Life Science Tech Unit Verily Raises $1B From Investors
Verily, Alphabet Inc's life sciences division, on Thursday announced a $1 billion investment round led by private equity firm Silver Lake. : (Reuters) - Verily, Alphabet Inc's (GOOGL.O) life sciences division, on Thursday announced a $1 billion investment round led by private equity firm Silver Lake. Alphabet Chief Financial Officer Ruth Porat and Silver Lake Managing Director Egon Durban will be nominated to Verily's operating board, the company said. Verily's existing board members include Chief Executive Andrew Conrad, Alphabet executives Larry Page, Sergey Brin and David Drummond and Temasek senior managing director Fidah Alsagoff, a company spokeswoman said.
Digital Health Megadeals Get Bigger In Q3 2018 | Fenwick & West Life Sciences Group
Just over a year ago, we reported about the rise of the mega-round in digital health investments. At that time, we tallied nine investment rounds valued at more than $100 million in the first half of 2017....By: Fenwick & West Life Sciences Group.
Blackstone Buys Clarus To Bulk Up In Life Sciences
Blackstone Group LP said on Thursday it has agreed to acquire life sciences investment firm Clarus, in an effort by the world's largest alternative asset manager to scale up its investments in healthcare.
Anju Software Harnesses The Power Of Life Sciences Data Through Acquisition Of Zephyr Health
NEW YORK--(BUSINESS WIRE)--Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, today announced that it has acquired San Francisco-based Zephyr Health, a company that provides comprehensive physician, institution and treatment data for every major disease area. Zephyr uses proprietary algorithms to link disparate data sources delivering actionable insights. With this acquisition, Anju continues to execute on combining robust software with actionable data t.
Xconomy: 3 Life Science Startups Join San Diego's Ad Astra Accelerator
Three San Diego life science startups have been selected to go through the Ad Astra Ventures accelerator program, a relatively new addition to the San Diego scene. Ad Astra, which means "to the stars" in Latin, was founded this year by three local entrepreneurs and investors interested in bolstering the efforts of women-led companies. Earlier [...]
Digital Health Investment Trends Q2 2018: Megadeals Become The Norm, China Rising | Fenwick & West Life Sciences Group
Private investment in digital health continued apace in the second quarter of 2018, based on our latest look at deal flow. As the sector has matured, growth in investment levels quarter-over-quarter and year-over-year appears sustainable for the...By: Fenwick & West Life Sciences Group.
Healthcare & Life Sciences Private Equity Deal Tracker: Cybermdx Raises $10m | Mcguirewoods Llp
CyberMDX has announced it has raised $10 million in series A financing. The funding round was led by Pitango Venture Capital. CyberMDX, based in New York, is a provider of medical cybersecurity....By: McGuireWoods LLP.
Benchling Raises $14.5m From Benchmark To Advance Life Sciences Research
Benchling Raises $14.5M From Benchmark to Advance Life Sciences Research Announces 500% ARR Growth and more than 100,000 scientists using its platform SAN FRANCISCO, June 14, 2018-- Today Benchling, the data management and collaboration platform built to advance life sciences research, announced it has closed $14.5M in Series B funding. The round was led by Benchmark, with participation from F-Prime Capital, a global venture capital firm associated with Fidelity Investments, and returning investor Thrive Capital. Benchmark General Partner Eric Vishria will be joining the board of directors.